Antitumor T Cell Responses in Patients With Bladder Cancer - Trial NCT06334406
Access comprehensive clinical trial information for NCT06334406 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire de Besancon and is currently Not yet recruiting. The study focuses on Bladder Cancer. Target enrollment is 33 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Centre Hospitalier Universitaire de Besancon
Timeline & Enrollment
N/A
Apr 02, 2024
Apr 02, 2026
Primary Outcome
Tumor antigen specific T-cell responses
Summary
The main objective of this study is to evaluate the induction of Th1 anti-TERT responses by
 treatments in patients with bladder tumor.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06334406
Non-Device Trial